Combination treatment with nivolumab and Rigvir of a progressive stage IIC skin melanoma patient

Abstract

Abstract A 35‐year‐old male patient was diagnosed with stage IIC skin melanoma that rapidly progressed after surgery. Treatment was continued with radiotherapy, which did not stop further spread of disease and the patient was put on a combination of nivolumab and Rigvir. Subsequently, the progression has slowed.

Keywords

• combination treatment
• metastatic melanoma
• nivolumab
• oncolytic virus
• Rigvir